Results 91 to 100 of about 3,952 (181)

Engineering HSV-1 for oncolytic therapy: From molecular entry mechanisms to retargeting strategies. [PDF]

Genes Dis
Zou Y, Tao J, Gao Y, Wang J, Wang P, Yan J, Nie Z, Jiang D, Huang X.   +8 more
europepmc   +1 more source

An Expanded Toolbox for Versatile Chemical Editing of Adeno-Associated Virus. [PDF]

Angew Chem Int Ed Engl
Pham Q, Glicksman J, Han B, Koo D, Loynd C, Singha Roy SJ, Chatterjee A.   +6 more
europepmc   +1 more source

Advances in endothelial cell targeting by AAV vectors. [PDF]

Acta Biochim Pol
Cichon M, Jozkowicz A, Grochot-Przeczek A.   +2 more
europepmc   +1 more source

N-terminal modifications as fate switches in neurodegeneration: a mechanistic review. [PDF]

Front Aging Neurosci
Mukherjee D, Raghul Kannan S, Tamizhselvi R.   +2 more
europepmc   +1 more source

A modular, single-protein envelope for targeted gene delivery. [PDF]

Mol Ther Oncol
Ding X.
europepmc   +1 more source

A novel feature fusion model to mimic photographers' active observation for scenery recomposition toward physical education. [PDF]

Sci Rep
Tang D, Wang S.
europepmc   +1 more source

Engineered retargeting to overcome systemic delivery challenges in oncolytic adenoviral therapy. [PDF]

Mol Ther Oncol
Leparc L, Wakimoto H.
europepmc   +1 more source

A facile chemical strategy to synthesize precise AAV-protein conjugates for targeted gene delivery. [PDF]

Mol Ther Oncol
Pham Q, Glicksman J, Han B, Shahraeini SS, Jewel D, Loynd C, Singha Roy SJ, Chatterjee A.   +7 more
europepmc   +1 more source

Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21. [PDF]

Mol Ther Oncol
Weiss F, Kolibius J, Freitag PC, Gantenbein F, Kipar A, Plückthun A.   +5 more
europepmc   +1 more source

Fourth-generation gene editors: Integration-based genome engineering. [PDF]

Mol Ther Adv
Kincaid AE, Hewitt AW, Kc R.
europepmc   +1 more source